Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | MBQ-167 |
Synonyms | |
Therapy Description |
MBQ-167 inhibits Rac1 and Cdc42, resulting in decreased downstream signaling, increased cell-cycle arrest, and reduced tumor growth and metastasis (PMID: 28450422, PMID: 31720502). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
MBQ-167 | MBQ-167 inhibits Rac1 and Cdc42, resulting in decreased downstream signaling, increased cell-cycle arrest, and reduced tumor growth and metastasis (PMID: 28450422, PMID: 31720502). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06075810 | Phase I | MBQ-167 | A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer | Recruiting | USA | 1 |